Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings
- PMID: 8408666
Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings
Abstract
Children's and parent's subjective ratings of the frequency and severity of nausea and emesis were assessed among 33 children with acute lymphoblastic leukemia receiving identical chemotherapy. Parents were trained to record the frequency of the child's actual emesis episodes during chemotherapy. Although parent and child ratings of nausea were significantly correlated, children generally rated their nausea and emesis as more frequent and more severe than did their parents. Parent ratings showed inadequate external validity when compared with behavioral observations. Children with greater anxiety and higher subjective ratings subsequently exhibited more frequent episodes of emesis by observation, suggesting that their perceptions of symptoms based on previous chemotherapy experiences may predict emesis during different chemotherapy. In a stepwise multiple regression analysis, antiemetic regimen and the child's anxiety as rated by the parent combined to account for approximately 47% of the variance in number of episodes of emesis. These findings are discussed in the context of factors limiting validity of parent and child reports of children's symptomatology with implications for future epidemiologic and intervention research.
Similar articles
-
Acute and delayed nausea and emesis control in pediatric oncology patients.Cancer. 2006 Feb 15;106(4):931-40. doi: 10.1002/cncr.21631. Cancer. 2006. PMID: 16404740
-
A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer.Am J Pediatr Hematol Oncol. 1984 Spring;6(1):5-16. Am J Pediatr Hematol Oncol. 1984. PMID: 6711763
-
Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.Support Care Cancer. 1998 Mar;6(2):132-8. doi: 10.1007/s005200050147. Support Care Cancer. 1998. PMID: 9540172
-
Comparative activity of antiemetic drugs.Crit Rev Oncol Hematol. 2007 Feb;61(2):162-75. doi: 10.1016/j.critrevonc.2006.08.003. Crit Rev Oncol Hematol. 2007. PMID: 17208005 Review.
-
Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.Expert Opin Drug Saf. 2004 May;3(3):231-48. doi: 10.1517/eods.3.3.231.31076. Expert Opin Drug Saf. 2004. PMID: 15155151 Review.
Cited by
-
Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children.Paediatr Drugs. 2003;5(9):597-613. doi: 10.2165/00148581-200305090-00003. Paediatr Drugs. 2003. PMID: 12956617 Review.
-
Coping strategies and anxiety in association with methotrexate-induced nausea in juvenile idiopathic arthritis.Rheumatol Int. 2020 Apr;40(4):591-598. doi: 10.1007/s00296-020-04520-9. Epub 2020 Jan 29. Rheumatol Int. 2020. PMID: 31996982
-
The association between glucocorticoid therapy and BMI z-score changes in children with acute lymphoblastic leukemia.Support Care Cancer. 2015 Dec;23(12):3573-80. doi: 10.1007/s00520-015-2718-5. Epub 2015 Apr 17. Support Care Cancer. 2015. PMID: 25894880
-
Symptom assessment in cancer patients.Curr Oncol Rep. 2002 May;4(3):256-63. doi: 10.1007/s11912-002-0024-0. Curr Oncol Rep. 2002. PMID: 11937017 Review.
-
Cost-effectiveness analysis of tropisetron vs. chlorpromazine-dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in children.Pharm World Sci. 1999 Apr;21(2):60-8. doi: 10.1023/a:1008693706516. Pharm World Sci. 1999. PMID: 10380232
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical